{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:37:24Z","timestamp":1775554644775,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Treatment-related mortality and morbidity remain a challenge in hematopoietic stem cell transplantation (HSCT). In this retrospective, single-center study, we analyzed endothelial damage as a potential, common denominator and mechanism for the adverse effects. We evaluated the prevalence of key vascular complications and graft-versus-host disease among 122 pediatric patients with an allogeneic HSCT between 2001 and 2013. The spectrum and frequency of acute adverse events emerging \u2264100 days post transplant were graded according to the CTCAE 4.03 and analyzed. We identified a total of 19\/122 (15.6%) patients with vascular complications, fulfilling the criteria of capillary leak syndrome, veno-occlusive disease\/sinusoidal obstruction syndrome or thrombotic microangiopathy. The patients had a poorer overall survival (77% versus 26%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Nearly one half (56\/122, 45.9%) had at least one, severe (grade 3 or 4) adverse event. Patients with vascular complications had more often edema\/effusions (<jats:italic>p<\/jats:italic>\u2009=\u20090.023), thrombocytopenia (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), gastrointestinal bleeding (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), acute kidney injury (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), ascites (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) or bilirubin increase (<jats:italic>p<\/jats:italic>\u2009=\u20090.027). These endotheliopathy-related adverse events appeared early post HSCT, varied in their clinical phenotype and predicted a poor outcome. An unrelated donor but not previous exposure to leukemia or irradiation-based conditioning was identified as a risk factor for vascular complications and endotheliopathy.<\/jats:p>","DOI":"10.1038\/s41409-022-01607-8","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T08:02:38Z","timestamp":1645084958000},"page":"705-711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Early vascular toxicity after pediatric allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0774-7110","authenticated-orcid":false,"given":"Lilli","family":"Leimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsi","family":"Jahnukainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Olkinuora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Vettenranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"1607_CR1","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363:2091\u2013101.","journal-title":"N Engl J Med"},{"key":"1607_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/bmt.2015.250","volume":"51","author":"E Brissot","year":"2016","unstructured":"Brissot E, Rialland F, Cahu X, Strullu M, Corradini N, Thomas C, et al. Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution. Bone Marrow Transplant. 2016;51:267\u201372.","journal-title":"Bone Marrow Transplant"},{"key":"1607_CR3","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/pbc.24559","volume":"60","author":"MK Mateos","year":"2013","unstructured":"Mateos MK, O\u2019Brien TA, Oswald C, Gabriel M, Ziegler DS, Cohn RJ, et al. Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review. Pediatr Blood Cancer. 2013;60:1520\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"1607_CR4","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/bmt.2017.119","volume":"52","author":"M Zeisbrich","year":"2017","unstructured":"Zeisbrich M, Becker N, Benner A, Radujkovic A, Schmitt K, Beimler J, et al. Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD. Bone Marrow Transplant. 2017;52:1399\u2013405.","journal-title":"Bone Marrow Transplant"},{"key":"1607_CR5","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","volume":"118","author":"T Luft","year":"2011","unstructured":"Luft T, Dietrich S, Falk C, Conzelmann M, Hess M, Benner A, et al. Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system. Blood. 2011;118:1685\u201392.","journal-title":"Blood"},{"key":"1607_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","volume":"22","author":"JH Dalle","year":"2016","unstructured":"Dalle JH, Giralt SA. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant. 2016;22:400\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1607_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood. 2014;124:645\u201353.","journal-title":"Blood"},{"key":"1607_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","volume":"54","author":"S Jodele","year":"2016","unstructured":"Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, et al. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transfus Apheresis Sci. 2016;54:181\u201390.","journal-title":"Transfus Apheresis Sci"},{"key":"1607_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2011.65","volume":"46","author":"E Carreras","year":"2011","unstructured":"Carreras E, Diaz-Ricart M. The role of the endothelium in the short-term complications of hematopoietic SCT. Bone Marrow Transplant. 2011;46:1495\u2013502.","journal-title":"Bone Marrow Transplant"},{"key":"1607_CR10","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/petr.12831","volume":"20","author":"G Lucchini","year":"2016","unstructured":"Lucchini G, Willasch AM, Daniel J, Soerensen J, Jarisch A, Bakhtiar S, et al. Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study. Pediatr Transplant. 2016;20:1132\u20136.","journal-title":"Pediatr Transplant"},{"key":"1607_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:571\u20135.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1607_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/leu.2009.251","volume":"24","author":"K Schmiegelow","year":"2010","unstructured":"Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, S\u00f6derh\u00e4ll S, et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia. 2010;24:345\u201354.","journal-title":"Leukemia"},{"key":"1607_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2017.265","volume":"32","author":"N Toft","year":"2018","unstructured":"Toft N, Birgens H, Abrahamsson J, Gri\u0161kevi\u010dius L, Hallb\u00f6\u00f6k H, Heyman M, et al. Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia. Leukemia. 2018;32:606\u201315.","journal-title":"Leukemia"},{"key":"1607_CR14","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1038\/sj.leu.2403962","volume":"19","author":"SO Lie","year":"2005","unstructured":"Lie SO, Abrahamsson J, Clausen N, Forestier E, Hasle H, Hovi L, et al. Long-term results in children with AML: NOPHO-AML Study Group \u2013 report of three consecutive trials. Leukemia. 2005;19:2090\u2013100.","journal-title":"Leukemia"},{"key":"1607_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1200\/JCO.2010.30.6829","volume":"29","author":"J Abrahamsson","year":"2011","unstructured":"Abrahamsson J, Forestier E, Heldrup J, Jahnukainen K, J\u00f3nsson \u00d3G, Lausen B, et al. Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. J Clin Oncol. 2011;29:310\u20135.","journal-title":"J Clin Oncol"},{"key":"1607_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/pbc.24679","volume":"61","author":"DM Green","year":"2014","unstructured":"Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava D, Leisenring WM, et al. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014;61:53\u201367.","journal-title":"Pediatr Blood Cancer"},{"key":"1607_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1542\/peds.2007-0575","volume":"121","author":"SM Shankar","year":"2008","unstructured":"Shankar SM, Marina N, Hudson MM, Hodgson DC, Adams MJ, Landier W, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children\u2019s Oncology Group. Pediatrics. 2008;121:387\u201396.","journal-title":"Pediatrics"},{"key":"1607_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295\u2013304.","journal-title":"Transplantation"},{"key":"1607_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90:918\u201326.","journal-title":"Transplantation"},{"key":"1607_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","volume":"53","author":"S Corbacioglu","year":"2018","unstructured":"Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2018;53:138\u201345.","journal-title":"Bone Marrow Transplant"},{"key":"1607_CR21","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1182\/bloodadvances.2019000143","volume":"3","author":"S Pagliuca","year":"2019","unstructured":"Pagliuca S, Michonneau D, Sicre de Fontbrune F, Sutra Del Galy A, Xhaard A, Robin M, et al. Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions. Blood Adv. 2019;3:2424\u201335.","journal-title":"Blood Adv"},{"key":"1607_CR22","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41409-020-0818-4","volume":"55","author":"T Nava","year":"2020","unstructured":"Nava T, Ansari M, Dalle JH, de Heredia CD, G\u00fcng\u00f6r T, Trigoso E, et al. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2020;55:1126\u201336.","journal-title":"Bone Marrow Transplant"},{"key":"1607_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","volume":"40","author":"ED Batts","year":"2007","unstructured":"Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant. 2007;40:709\u201319.","journal-title":"Bone Marrow Transplant"},{"key":"1607_CR24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/bmt.2009.230","volume":"45","author":"E Willems","year":"2010","unstructured":"Willems E, Baron F, Seidel L, Frere P, Fillet G, Beguin Y. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplant. 2010;45:689\u201393.","journal-title":"Bone Marrow Transplant"},{"key":"1607_CR25","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/bmt.2017.39","volume":"52","author":"E Gavriilaki","year":"2017","unstructured":"Gavriilaki E, Sakellari I, Anagnostopoulos A, Brodsky RA. Transplant-associated thrombotic microangiopathy: opening Pandora\u2019s box. Bone marrow Transplant. 2017;52:1355\u201360.","journal-title":"Bone marrow Transplant"},{"key":"1607_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ajh.20648","volume":"81","author":"H Nakamae","year":"2006","unstructured":"Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, et al. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2006;81:525\u201331.","journal-title":"Am J Hematol"},{"key":"1607_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/JBM.S102235","volume":"7","author":"J Rosenthal","year":"2016","unstructured":"Rosenthal J. Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment. J Blood Med. 2016;7:181\u20136.","journal-title":"J Blood Med"},{"key":"1607_CR28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","volume":"127","author":"S Jodele","year":"2016","unstructured":"Jodele S, Zhang K, Zou F, Laskin B, Dandoy CE, Myers KC, et al. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood. 2016;127:989\u201396.","journal-title":"Blood"},{"key":"1607_CR29","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","volume":"122","author":"S Jodele","year":"2013","unstructured":"Jodele S, Licht C, Goebel J, Dixon BP, Zhang K, Sivakumaran TA, et al. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood. 2013;122:2003\u20137.","journal-title":"Blood"},{"key":"1607_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1076029615598221","volume":"22","author":"O Elsallabi","year":"2016","unstructured":"Elsallabi O, Bhatt VR, Dhakal P, Foster KW, Tendulkar KK. Hematopoietic stem cell transplant-associated thrombotic microangiopathy. Clin Appl Thrombosis\/Hemost. 2016;22:12\u201320.","journal-title":"Clin Appl Thrombosis\/Hemost"},{"key":"1607_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","volume":"29","author":"S Jodele","year":"2015","unstructured":"Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015;29:191\u2013204.","journal-title":"Blood Rev"},{"key":"1607_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/bmt.2009.230","volume":"45","author":"E Willems","year":"2010","unstructured":"Willems E, Baron F, Seidel L, Fr\u00e8re P, Fillet G, Beguin Y. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplant. 2010;45:689\u201393.","journal-title":"Bone Marrow Transplant"},{"key":"1607_CR33","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hon.2346","volume":"35","author":"I Sakellari","year":"2017","unstructured":"Sakellari I, Gavriilaki E, Boussiou Z, Batsis I, Mallouri D, Constantinou V, et al. Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases. Hematological Oncol. 2017;35:932\u20134.","journal-title":"Hematological Oncol"},{"key":"1607_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","volume":"14","author":"KR Cooke","year":"2008","unstructured":"Cooke KR, Jannin A, Ho V. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2008;14:23\u201332.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1607_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.bbmt.2018.10.015","volume":"25","author":"A Li","year":"2019","unstructured":"Li A, Wu Q, Davis C, Kirtane KS, Pham PD, Sorror ML, et al. Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal. Biol Blood Marrow Transplant. 2019;25:570\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1607_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","volume":"5","author":"CE Dandoy","year":"2020","unstructured":"Dandoy CE, Rotz S, Alonso PB, Klunk A, Desmond C, Huber J, et al. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood Adv. 2020;5:1\u201311.","journal-title":"Blood Adv"},{"key":"1607_CR37","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.3389\/fimmu.2019.03098","volume":"10","author":"E Pierik","year":"2020","unstructured":"Pierik E, Prins JR, van Goor H, Dekker GA, Daha MR, Seelen MAJ, et al. Dysregulation of complement activation and placental dysfunction: a potential target to treat preeclampsia? Front Immunol. 2020;10:3098.","journal-title":"Front Immunol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01607-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T14:04:03Z","timestamp":1652191443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01607-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1038\/s41409-022-01607-8","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}